Pharmaceuticals in Mexico
Pharmaceuticals in Mexico
SUMMARY
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Mexican pharmaceuticals market had total revenues of $5,289.3m in 2019, representing a compound annual growth rate (CAGR) of 2.4% between 2015 and 2019.
- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products, including generics, in Mexico.
- Poor diets, most notably amongst the lower income population, and a shift to sedentary job roles and lifestyle habits will continue to drive growth in the Mexican market.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
- What was the size of the Mexico pharmaceuticals market by value in 2019?
- What will be the size of the Mexico pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Mexico's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How does government regulation impact leading players?
7.5. Are there any other notable players present?
7.6. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How does government regulation impact leading players?
7.5. Are there any other notable players present?
7.6. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Pfizer Inc.
8.3. Merck & Co., Inc.
8.4. Novartis AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Mexico pharmaceuticals market value: $ billion, 2015-19
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Mexico pharmaceuticals market share: % share, by value, 2019
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: Merck & Co., Inc.: key facts
Table 13: Merck & Co., Inc.: Annual Financial Ratios
Table 14: Merck & Co., Inc.: Key Employees
Table 15: Merck & Co., Inc.: Key Employees Continued
Table 16: Novartis AG: key facts
Table 17: Novartis AG: Annual Financial Ratios
Table 18: Novartis AG: Annual Financial Ratios (Continued)
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: Mexico size of population (million), 2015-19
Table 22: Mexico gdp (constant 2005 prices, $ billion), 2015-19
Table 23: Mexico gdp (current prices, $ billion), 2015-19
Table 24: Mexico inflation, 2015-19
Table 25: Mexico consumer price index (absolute), 2015-19
Table 26: Mexico exchange rate, 2015-19
Table 1: Mexico pharmaceuticals market value: $ billion, 2015-19
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Mexico pharmaceuticals market share: % share, by value, 2019
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: Annual Financial Ratios
Table 10: Pfizer Inc.: Key Employees
Table 11: Pfizer Inc.: Key Employees Continued
Table 12: Merck & Co., Inc.: key facts
Table 13: Merck & Co., Inc.: Annual Financial Ratios
Table 14: Merck & Co., Inc.: Key Employees
Table 15: Merck & Co., Inc.: Key Employees Continued
Table 16: Novartis AG: key facts
Table 17: Novartis AG: Annual Financial Ratios
Table 18: Novartis AG: Annual Financial Ratios (Continued)
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: Mexico size of population (million), 2015-19
Table 22: Mexico gdp (constant 2005 prices, $ billion), 2015-19
Table 23: Mexico gdp (current prices, $ billion), 2015-19
Table 24: Mexico inflation, 2015-19
Table 25: Mexico consumer price index (absolute), 2015-19
Table 26: Mexico exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Mexico pharmaceuticals market value: $ billion, 2015-19
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2019
Figure 10: Mexico pharmaceuticals market share: % share, by value, 2019
Figure 1: Mexico pharmaceuticals market value: $ billion, 2015-19
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2019
Figure 10: Mexico pharmaceuticals market share: % share, by value, 2019
